The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.
Also called NCT07162792
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Xuzhou Third People's Hospital
- Registry
-
NCT07162792
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07162792. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-23 (anticipated); primary completion 2027-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT
- Condition
- de Novo Coronary Lesions
- Intervention (Device)
- bioresorbable scaffold
- Intervention (Device)
- drug-coated balloon
- Lead sponsor
- Xuzhou Third People's Hospital
Record details
- Record id
cardio:ct-nct07162792- Content hash
2618669a14b1135408bb1075febed95c5e0a8c7c0d12225d9c3e521bebb20dfc